Next 10 |
home / stock / appdw / appdw news
Revenues Increased 294% Year-Over-Year to $1.7 Million – Year-To-Date Revenues Increase 270% From Last Fiscal Year to $6.0 Million – - Company to Hold Conference Call and Webcast Today, Thursday, August 12, 2021, at 4:30 PM ET - Applied DNA Scienc...
- Ensures Customer’s Continuing Access to Assay Kit for Pooled Surveillance Testing Program - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturin...
- Claimed methods have applicability in the DNA tagging of pharmaceutical, nutraceutical and personal care excipients - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-base...
- Average Daily Testing in January 2021 to Date Up 158% Over December 2020, Driven Primarily by Scale Up in Testing Contracts - - Company Increases Production of Assay Kits (Tests) and Sample Collection Kits to Meet Further Demand - - Applied DNA Clinical Laboratories ...
- Early and Cost-Effective Identification of Samples Potentially Containing the B.1.1.7 or Other Variants May Help Reduce Further Spread of Infection - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based ...
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it expects revenues for the first fiscal quarter of 2021 ended December 31, 2020, to be in th...
- Receives Second Warrant Exercise Subsequent to Year-End for Net Proceeds of $1.05 Million – - Company to Hold Conference Call and Webcast Today, Thursday, December 17, 2020 at 4:30 PM ET - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”...
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its wholly-owned subsidiary, Applied DNA Clinical Laboratories, LLC (ADCL), has secured a safeCircle™...
- ADCL Signs Agreements with Schools and Colleges with a Potential Weekly Testing Population of >5,000 Individuals, Some Agreements Contingent on Funding; Sales Pipeline Exceeds 20 Schools - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Co...
– Trial Redesigned to Accelerate Development of Clinical Path to Potential USDA APHIS Conditional License for Commercial Veterinary Sales – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Re...
News, Short Squeeze, Breakout and More Instantly...
Applied Dna Sciences Inc - Warrants (15/11/2024) Company Name:
APPDW Stock Symbol:
OTCMKTS Market:
Revenues Increased 294% Year-Over-Year to $1.7 Million – Year-To-Date Revenues Increase 270% From Last Fiscal Year to $6.0 Million – - Company to Hold Conference Call and Webcast Today, Thursday, August 12, 2021, at 4:30 PM ET - Applied DNA Scienc...
- Ensures Customer’s Continuing Access to Assay Kit for Pooled Surveillance Testing Program - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturin...
- Claimed methods have applicability in the DNA tagging of pharmaceutical, nutraceutical and personal care excipients - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-base...